| Genomic predictors of outcome in prostate cancer PJ Boström, AS Bjartell, JWF Catto, SE Eggener, H Lilja, S Loeb, ... European urology 68 (6), 1033-1044, 2015 | 214 | 2015 |
| Risk factors for mortality and morbidity related to radical cystectomy PJ Boström, J Kössi, M Laato, M Nurmi BJU international 103 (2), 191-196, 2009 | 191 | 2009 |
| Nutraceuticals and prostate cancer prevention: a current review G Trottier, PJ Boström, N Lawrentschuk, NE Fleshner Nature Reviews Urology 7 (1), 21-30, 2010 | 155 | 2010 |
| Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: preliminary findings from a multi‐institutional study SB Ginsburg, A Algohary, S Pahwa, V Gulani, L Ponsky, HJ Aronen, ... Journal of Magnetic Resonance Imaging 46 (1), 184-193, 2017 | 140 | 2017 |
| Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization J Toivonen, I Montoya Perez, P Movahedi, H Merisaari, M Pesola, ... PloS one 14 (7), e0217702, 2019 | 102 | 2019 |
| Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial) I Jambor, PJ Boström, P Taimen, K Syvänen, E Kähkönen, M Kallajoki, ... Journal of Magnetic Resonance Imaging 46 (4), 1089-1095, 2017 | 98 | 2017 |
| Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort G Trottier, MJ Roobol, N Lawrentschuk, PJ Boström, KA Fernandes, ... BJU international 108 (8b), E237-E244, 2011 | 97 | 2011 |
| Randomised trial of adjuvant radiotherapy following radical prostatectomy versus radical prostatectomy alone in prostate cancer patients with positive margins or extracapsular … G Hackman, K Taari, TL Tammela, M Matikainen, M Kouri, T Joensuu, ... European urology 76 (5), 586-595, 2019 | 94 | 2019 |
| Evaluation of different mathematical models for diffusion‐weighted imaging of normal prostate and prostate cancer using high b‐values: a repeatability study I Jambor, H Merisaari, P Taimen, P Boström, H Minn, M Pesola, ... Magnetic resonance in medicine 73 (5), 1988-1998, 2015 | 91 | 2015 |
| Expression of collagenase‐3 (matrix metalloproteinase‐13) in transitional‐cell carcinoma of the urinary bladder PJ Boström, L Ravanti, N Reunanen, V Aaltonen, KO Söderström, ... International journal of cancer 88 (3), 417-423, 2000 | 89 | 2000 |
| Mathematical models for diffusion‐weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of … J Toivonen, H Merisaari, M Pesola, P Taimen, PJ Boström, T Pahikkala, ... Magnetic resonance in medicine 74 (4), 1116-1124, 2015 | 83 | 2015 |
| A prospective comparison of 18F-prostate-specific membrane antigen-1007 positron emission tomography computed tomography, whole-body 1.5 T magnetic resonance imaging with … M Anttinen, O Ettala, S Malaspina, I Jambor, M Sandell, S Kajander, ... European urology oncology 4 (4), 635-644, 2021 | 79 | 2021 |
| Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction H Merisaari, P Movahedi, IM Perez, J Toivonen, M Pesola, P Taimen, ... Magnetic resonance in medicine 77 (3), 1249-1264, 2017 | 78 | 2017 |
| Tumor-associated macrophages provide significant prognostic information in urothelial bladder cancer MM Boström, H Irjala, T Mirtti, P Taimen, T Kauko, A Ålgars, S Jalkanen, ... PloS one 10 (7), e0133552, 2015 | 76 | 2015 |
| Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial) I Jambor, A Kuisma, E Kähkönen, J Kemppainen, H Merisaari, O Eskola, ... European journal of nuclear medicine and molecular imaging 45, 355-364, 2018 | 73 | 2018 |
| Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning: a retrospective multi-institutional study using the … UG Falagario, I Jambor, A Lantz, O Ettala, A Stabile, P Taimen, HJ Aronen, ... European urology oncology 4 (6), 971-979, 2021 | 66 | 2021 |
| Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: a prospective multi-institutional trial I Jambor, J Verho, O Ettala, J Knaapila, P Taimen, KT Syvänen, ... PLoS medicine 16 (6), e1002813, 2019 | 59 | 2019 |
| Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy K Lahdensuo, A Erickson, I Saarinen, H Seikkula, J Lundin, M Lundin, ... Modern Pathology 29 (12), 1565-1574, 2016 | 56 | 2016 |
| SORLA regulates endosomal trafficking and oncogenic fitness of HER2 M Pietilä, P Sahgal, E Peuhu, NZ Jäntti, I Paatero, E Närvä, H Al-Akhrass, ... Nature Communications 10 (1), 2340, 2019 | 55 | 2019 |
| Validation of novel biomarkers for prostate cancer progression by the combination of bioinformatics, clinical and functional studies S Alinezhad, RM Väänänen, J Mattsson, Y Li, T Tallgren, N Tong Ochoa, ... PloS one 11 (5), e0155901, 2016 | 53 | 2016 |
